TD Asset Management’s Oric Pharmaceuticals ORIC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.8M | Buy |
177,700
+25,000
| +16% | +$254K | ﹤0.01% | 966 |
|
|
2025
Q1 | $852K | Buy |
152,700
+4,900
| +3% | +$27.3K | ﹤0.01% | 1096 |
|
|
2024
Q4 | $1.19M | Buy |
147,800
+8,400
| +6% | +$67.8K | ﹤0.01% | 1093 |
|
|
2024
Q3 | $1.48M | Hold |
139,400
| – | – | ﹤0.01% | 1121 |
|
|
2024
Q2 | $986K | Sell |
139,400
-69,200
| -33% | -$489K | ﹤0.01% | 1161 |
|
|
2024
Q1 | $2.87M | Buy |
208,600
+127,800
| +158% | +$1.76M | ﹤0.01% | 913 |
|
|
2023
Q4 | $743K | Buy |
+80,800
| New | +$743K | ﹤0.01% | 1242 |
|